Skip to main content
Clinical Trials/CTRI/2023/04/051952
CTRI/2023/04/051952
Not yet recruiting
未知

A Prospective Randomised Study To Evaluate Efficacy And Safety between Two Different Dose Fractionation Schedule Of Interstitial Brachytherapy In Treatment Of Patients With Carcinoma of Uterine Cervix

SVIMS0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C531- Malignant neoplasm of exocervix
Sponsor
SVIMS
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
SVIMS

Eligibility Criteria

Inclusion Criteria

  • Histopathologically confirmed carcinoma of Uterine cervix
  • Patients of age group 18 to 70 years.
  • Patients with performance status of 0 to 2
  • Stage II B\- III C with intact cervix.
  • Patients with gross residual disease after EBRT not suitable for ICRT
  • Distorted Geometry like narrow vagina and os not soundable
  • Post hysterectomy Carcinoma vault
  • Post supra cervical hysterectomy with carcinoma of cervical stump.
  • Extensive para vaginal and distal vaginal involvement
  • Patients who has given approved informed consent

Exclusion Criteria

  • Patients with distant metastasis
  • Patients with prior EBRT and Brachytherapy to pelvis
  • Patients with ECOG performance status of 3\-4
  • Pregnant women and lactating mothers
  • Patients who has not given informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials